Dengue in travellers is still underestimated

Intervirology

Volumn 51, Issue 2, 2008, Pages 96-100

  Allwinn, Regina ^a   Hofknecht, Nina ^a   Doerr, Hans Wilhelm ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Dengue fever virus; Seroprevalence; Travel medicine

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGED; ARTICLE; CROSS REACTION; DENGUE; DENGUE VIRUS; ENDEMIC DISEASE; FEMALE; FLAVIVIRUS; GERMANY; HUMAN; IMMUNOASSAY; MALE; MOSQUITO; NORMAL HUMAN; PRIORITY JOURNAL; SEROPREVALENCE; TICK BORNE ENCEPHALITIS; TRAVEL; TROPICS; VACCINATION;

ADULT; AGED; ANTIBODIES, VIRAL; DENGUE; DENGUE VIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GERMANY; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; REAGENT KITS, DIAGNOSTIC; TRAVEL;

DENGUE VIRUS; FLAVIVIRUS; IXODIDA;

EID: 47549090988     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000131667     Document Type: Article

References (33)

1. Schmitz H, Emmerich P, ter Meulen J: Imported tropical virus infections in Germany. Arch Virol Suppl 1996;11:67-74.
2. Bulugahapitiya U, Siyambalapitiya S, Seneviratne SL, Fernando DJ: Dengue fever in travellers: a challenge for European physicians. Eur J Intern Med 2007;18:185-192.
3. Gibbons RV, Vaughn DW: Dengue: an escalating problem. BMJ 2002;324:1563-1566.
4. Stephan C, Allwinn R, Brodt H-R, Krupp B, Preiser W, Just-Nübling G: Epidemiology and clinical manifestations in travel-acquired dengue infection. Infection 2002;30:225-228.
5. Doerr HW, Allwinn R, Preiser W: Dengue fever;in Licker MD (ed): Year Book of Science and Technology. New York, McGraw Hill Professional Book Group, 2000, pp 109-112.
6. Monath TP: Dengue. The risk to developed and developing countries. Proc Natl Acad Sci USA 1994;91:2395-4000.
7. Halstead SB: Pathogenesis of dengue: challenges to molecular biology. Science 1988;239:476-481. http://www.who.int/mediacentre/factsheets/fs117/en/10.
8. Gubler DJ, Clark GG: Dengue/dengue hemorrhagic fever: the emergence of a global problem. Emerg Infect Dis 1995;1:55-57.
9. Gubler DJ: The global pandemic of dengue/dengue haemorrhagic fever: current status and prospects for the future. Ann Acad Med 1998;27:227-343.
10. Gubler DJ: Epidemic dengue/hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 2002;10:100-103.
11. Rigau-Perez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV: Dengue and dengue haemorrhagic fever. Lancet 1998;352:971-977.
12. World Health Organization: Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control, ed 2. Geneva, WHO, 1997.
13. Monath TP, Heinz FX: Flaviviruses; in Fields BN 3rd, Knipe DM, Howley PM (eds): Fields Virology. Philadelphia, Lippincott-Raven, 1996, pp 961-1034.
14. Lawn SD, Tiley R, Lloyd G, Finlayson C, Tolley H, Newman P, Rice P, Harrison TS: Dengue heamorrhagic fever with fulminant hepatic failure in an immigrant returning to Bangladesh. Clin Infect Dis 2003;37:e1-e4.
15. Jänisch T, Preiser W, Berger A, Niedrig M, Mikulicz U, Thoma B, Doerr HW: Emerging viral pathogens in long-term expatriates. II. Dengue virus. Trop Med Int Health 1997;2:934-940.
16. Dobler G, Jelinek T, Frosner G, Nothdurft HD, Löscher T: Cross reactions of patients with acute dengue fever to tick-borne encephalitis. Wien Med Wochenschr 1997;147:463-464.
17. Allwinn R, Doerr HW, Emmerich P, Schmitz H, Preiser W: Cross-reactivity in flavivirus serology: new implications of an old finding? Med Microbiol Immunol 2002;190:199-202.
18. O'Brien DP, Leder K, Matchett E, Brown GV, Torresi J: Illness in returned travellers and immigrants/refugees: the 6-year experience of two Australian infectious diseases units. J Travel Med 2006;13:145.
19. O'Brien DP, Tobin S, Brown GV, Torresi J: Fever in returned travellers: review of hospital admissions for a 3-year period. Clin Infect Dis 2001;33:603-609.
20. Eisenhut M, Schwarz TF, Hegenscheid B: Seroprevalence of dengue, chikungunya and Sindbis virus infections in German aid workers. Infection 1999;27:82-85.
21. Jelinek T: Dengue fever in international travellers. Clin Infect Dis 2000;31:144-147.
22. Wilder-Smith A, Schwartz E: Dengue in travellers. N Engl J Med 2005;353:924-932.
23. Wilder-Smith A, Tambyah PA: Severe dengue virus infection in travellers. J Infect Dis 2007;195:1081-1083.
24. Jelinek T, Muhlberger N, Harms G, Corachan M, Grobusch MP, Knobloch J, Bronner U, Laferl H, Kapaun A, Bisoffi Z, Clerinx J, Puente S, Fry G, Schulze M, Hellgren U, Gjorup I, Chalupa P, Hatz C, Matteelli A, Schmid M, Nielsen LN, da Cunha S, Atouguia J, Myrvang B, Fleischer K, European Network on Imported Infectious Disease Surveillance: Epidemiology and clinical features of imported dengue fever in Europe: sentinel surveillance data from TropNetEurop. Clin Infect Dis 2002;35:1047-1052.
25. Cobelens FG, Groen J, Osterhaus AD, Leentvaar-Kuipers A, Wertheim-van Dillen PM, Kager PA: Incidence and risk factors of probable dengue virus infection among Dutch travellers to Asia. Trop Med Int Health 2002;7:331-338.
26. Allwinn R, Schieferstein C, Klauke S, Doerr HW: Rapid diagnosis of primary dengue fever by the immunochromatographic test and by electron microscopy - a case report. Infection 1999;27:365-367.
27. Robert Koch Institut: FSME: zum aktuellen Vorkommen. Epidemiol Bull 2006;No 12.
28. Sang CT, Hoon LS, Cuzzubbo AJ, Devine PL: Clinical evaluation of a rapid immunochromatographic test for the diagnosis of dengue virus infection. Clin Diagn Lab Immunol 1998;5:407-409.
29. Schwartz E, Mileguir F, Grossmann Z, Mendelson E: Evaluation of ELISA-based serodiagnosis of dengue fever in travellers. J Clin Virol 2000;19:169-173.
30. Wichmann O, Mühlberger N, Jelinek T: Dengue - the underestimated risk in travellers. Bull WHO 2003;27:126-137.
31. Robert-Koch-Institut: Dengue-Fieber. Epidemiol Bull 2006;37:322-323.
32. Huhtamo E, Vuorinen S, Uzcátequi NY, Vapalathi O, Haapasalo H, Lumio J: Fatal dengue virus infection in a Finnish traveller. J Clin Virol 2006;37:323-326.
33. Deen J: The challenge of dengue vaccine development and introduction. Trop Med Int Health 2004;9:1-3.